Loading clinical trials...
Loading clinical trials...
Verification of Prognostic Risk Factors of Thrombohemorrhagic Complications in Early Follow-up Period in Recipients After Living Related Liver Transplantation
The aim of the study is to improve the results of related transplantation of the right liver lobe by verifying the general predictors of the development of hemostatic system disorders and optimizing a comprehensive program for thrombohemorrhagic complications preventing.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
No
Republican specialized scientific and practical medical center of surgery named after academician V.Vakhidov
Tashkent, Uzbekistan
Start Date
April 22, 2022
Primary Completion Date
November 14, 2026
Completion Date
December 16, 2026
Last Updated
December 30, 2025
30
ESTIMATED participants
Liver transplantation
PROCEDURE
Lead Sponsor
Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov
NCT07275554
NCT06855056
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions